跳至主要内容
临床试验/NCT02461576
NCT02461576已完成不适用

Clinical Evaluation of the Xpert® HIV-1 VL: A Method Comparison Study

Cepheid0 个研究点目标入组 966 人开始时间: 2015年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Cepheid
入组人数
966
主要终点
Quantification of HIV-1 RNA in copies/mL in known HIV-1 positive subjects

研究概览

简要总结

Compare the clinical performance of the Xpert® HIV-1 VL to another FDA approved HIV-1 RNA quantitative assay using frozen and fresh specimens from known HIV-1 positive individuals.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV-1 seropositive adults using an FDA approved method
  • At least 18 years of age or older
  • Informed consent, if applicable

排除标准

  • Subject is less than 18 years of age
  • Previously enrolled in this study
  • Samples not collected according to the procedure

结局指标

主要结局

Quantification of HIV-1 RNA in copies/mL in known HIV-1 positive subjects

时间窗: 1 day (A single time point)

This study is a comparative analysis of HIV-1 RNA quantitation between Xpert HIV-1 VL to another FDA approved test. A single time point (cross-sectional) from each of at least 300 subjects with HIV-1 RNA quantitation within the dynamic range of both assays will be used in regression models to assess performance of the Xpert HIV-1 VL in comparison to the other FDA approved test.

次要结局

未报告次要终点

研究者

发起方
Cepheid
申办方类型
Industry
责任方
Sponsor

相似试验